相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Phase II Study of Celecoxib in Combination with Paclitaxel, Carboplatin, and Radiotherapy for Patients with Inoperable Stage IIIA/B Non-Small Cell Lung Cancer
Robert Mutter et al.
CLINICAL CANCER RESEARCH (2009)
Estrogen potentiates constrictor prostanoid function in female rat aorta by upregulation of cyclooxygenase-2 and thromboxane pathway expression
Min Li et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Novel role of thromboxane receptors β isoform in bladder cancer pathogenesis
Omar Moussa et al.
CANCER RESEARCH (2008)
The potential predictive value of cyclooxygenase-2 expression and increased risk of gastrointestinal hemorrhage in advanced non-small cell lung cancer patients treated with erlotinib and celecoxib
Mary J. Fidler et al.
CLINICAL CANCER RESEARCH (2008)
Eicosanoid modulation in advanced lung cancer: Cyclooxygenase-2 expression is a positive predictive factor for celecoxib plus chemotherapy - Cancer and leukemia group B trial 30203
Martin J. Edelman et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Inhibition of thromboxane synthase activity modulates bladder cancer cell responses to chemotherapeutic agents
O. Moussa et al.
ONCOGENE (2008)
Targeting novel and established therapies for non-small cell lung cancer
James Spicer et al.
CANCER LETTERS (2007)
Activation of the thromboxane A2 pathway in human prostate cancer correlates with tumor Gleason score and pathologic stage
Thibaut Dassesse et al.
EUROPEAN UROLOGY (2006)
Upregulation of thromboxane synthase in human colorectal carcinoma and the cancer cell proliferation by thromboxane A2
Hideki Sakai et al.
FEBS LETTERS (2006)
Increased thromboxane B2 levels are associated with lipid peroxidation and Bcl-2 expression in human lung carcinoma
GG Chen et al.
CANCER LETTERS (2006)
Prognostic and functional significance of thromboxane synthase gene overexpression in invasive bladder cancer
O Moussa et al.
CANCER RESEARCH (2005)
Epidemiology of lung cancer: Looking to the future
AJ Alberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial
RS Bresalier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention
SD Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Role of COX-2, thromboxane A2 synthase, and prostaglandin I2 synthase in papillary thyroid carcinoma growth
S Kajita et al.
MODERN PATHOLOGY (2005)
Inhibition of the arachidonic acid metabolism blocks endothelial cell migration and induces apoptosis
J Jantke et al.
ACTA NEUROCHIRURGICA (2004)
Differential expression of thromboxane synthase in prostate carcinoma - Role in tumor cell motility
DT Nie et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Cyclooxygenase as a target in lung cancer
JR Brown et al.
CLINICAL CANCER RESEARCH (2004)
The risk of a venous thrombotic event in lung cancer patients: higher risk for adenocarcinoma than squamous cell carcinoma
JW Blom et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Markers of coagulation and angiogenesis in cancer-associated venous thromboembolism
N Goldenberg et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Cyclooxygenase-2 - 10 years later
B Hinz et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Prognostic significance of cyclooxygenase 2 mRNA expression in non-small cell lung cancer
J Brabender et al.
ANNALS OF SURGERY (2002)
Prostaglandins and leukotrienes: Advances in eicosanoid biology
CD Funk
SCIENCE (2001)
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis.
C Bombardier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Thromboxane A2 regulation of endothelial cell migration, angiogenesis, and tumor metastasis
DT Nie et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
分享论文
